Tag: antiretroviral therapy
-
Insights from a 44-Case Study: Gynecologic Cancers in HIV Patients (2020–2024)
Background and Purpose The advent of antiretroviral therapy (ART) has dramatically increased life expectancy for people living with HIV. As patients live longer, the spectrum of health concerns has shifted, with non-AIDS-defining cancers, particularly gynecologic malignancies, emerging as a significant issue. This study examines 44 cases from 2020 to 2024 to understand patterns in incidence,…
-
Core-Shell Fiber Technology: Enhancing Antiretroviral Delivery and HIV Therapy
Introduction The ongoing fight against HIV continues to rely on advances in treatment strategies that improve adherence, reduce side effects, and extend drug efficacy. Among the promising developments is the use of core-shell fiber systems for antiretroviral (ART) delivery. These nanoscale or microscale fibers, engineered with a core-shell architecture, offer unique control over drug release…
-
Factors Influencing Antiretroviral Therapy Completion Among People Living with HIV
Introduction Antiretroviral Therapy (ART) has transformed HIV from a fatal infection into a manageable chronic condition for many people living with HIV. Yet, achieving and maintaining ART completion—consistently taking the prescribed medication until treatment goals are reached—remains a complex challenge. Completion depends on a mix of individual, clinical, and systemic factors that interact over time.…
-
Warning Signs of HIV/AIDS and What 5 Doctors Want You to Know
Understanding HIV/AIDS: Why Awareness Matters Human Immunodeficiency Virus (HIV) attacks the body’s defenses, and if untreated, can progress to Acquired Immunodeficiency Syndrome (AIDS). Early detection is crucial. Women are disproportionately affected by HIV, accounting for a large share of new infections in many regions, including India. Stigma, gender inequality, and limited awareness of prevention tools…
-
Low HBV Reactivation Risk After Tenofovir Withdrawal in People with HIV: New EACS 2025 Findings
Background: Tenofovir and HBV in HIV Care Tenofovir has been a cornerstone of antiretroviral therapy (ART) for people living with HIV, partly because it also provides activity against hepatitis B virus (HBV). For patients with past HBV exposure who are virologically suppressed, clinicians have explored strategies to reduce long-term drug toxicity—especially renal and bone side…
-
Low Risk of HBV Reactivation After Tenofovir Withdrawal in People With HIV
New evidence supports safety of tenofovir-sparing ART in HBV-immune people with HIV Emerging data presented at the 2025 European AIDS Clinical Society (EACS) Congress suggest that stopping tenofovir in people with HIV who have prior hepatitis B exposure poses a very small risk of hepatitis B virus (HBV) reactivation. The findings come from the Swiss…
-
Fiji’s HIV Surge: Bluetoothing, Chemsex and Needles
Overview: A rising crisis in a small island nation Fiji, a Pacific nation with fewer than a million people, is facing one of the world’s fastest-growing HIV epidemics. From fewer than 500 people living with HIV in 2014, the country recorded about 5,900 by 2024 and 1,583 new cases in that year alone. Public health…